Latest Revenue Growth News

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

Viva Leisure has lifted its FY26 net profit after tax guidance by more than 130%, driven by strong margins and a booming technology segment, while reaffirming revenue and EBITDA targets.

New Zealand King Salmon (NZK) reversed prior losses with a $13.8 million net profit in 1HY26, upgrading its full-year earnings outlook and advancing key growth infrastructure.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Little Green Pharma has secured Federal Court approval for its full acquisition of Cannatrek, marking a key milestone in expanding its global medicinal cannabis footprint. The scheme became effective on 25 May 2026, with implementation set for 1 June.

IMEXHS has landed a significant public tender in Mexico, deploying its AI-powered Aquila+ radiology platform across 20 hospitals, adding $384,000 in new annual recurring revenue and advancing its Latin American expansion.

Adore Beauty Group reports a 7.4% revenue rise in FY26 despite market headwinds and outlines ambitious FY27 targets backed by new stores and operational efficiencies.

SSH Group has finalised its acquisition of Elphinstone Mechanical Services, significantly boosting its industrial mining services and workforce capabilities across Western Australia and Queensland.

Vodafone Group Plc’s 2026 Annual Report reveals a transformative year marked by the full consolidation of VodafoneThree UK after a landmark merger, acquisition of Telekom Romania and Skaylink, and a planned controlling stake in Safaricom. The Group achieved strong financial results, increased dividends, and reinforced ESG commitments across Europe and Africa.

Radius Residential Care has syndicated its bank debt, boosting facility limits by NZD 30 million and cutting financing costs by 65 basis points to support its growth plans, including a new care home acquisition and development projects.

EROAD reported flat group revenue of NZD 195.2 million for FY26, driven by strong Australian growth and steady New Zealand performance, offset by a North American decline and a hefty goodwill impairment.

Appen Limited's FY25 results reveal solid revenue growth driven by generative AI projects and a standout performance from its China segment. The company sets FY26 revenue guidance of $270-300 million, underpinned by operational efficiencies and expanding AI data services.